Detalles de la búsqueda
1.
Salvage haploidentical or cord-blood allogeneic stem cell transplantation after a prior alternative allograft in hematologic malignancies: A retrospective study from the SFGM-TC.
Eur J Haematol;
110(1): 40-49, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36151965
2.
Long-term event-free survival, chimerism and fertility outcomes in 234 patients with sickle-cell anemia younger than 30 years after myeloablative conditioning and matched-sibling transplantation in France.
Haematologica;
105(1): 91-101, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31097628
3.
Mainly Post-Transplant Factors Are Associated with Invasive Aspergillosis after Allogeneic Stem Cell Transplantation: A Study from the Surveillance des Aspergilloses Invasives en France and Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.
Biol Blood Marrow Transplant;
25(2): 354-361, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30268782
4.
Similar outcome of allogeneic stem cell transplantation after myeloablative and sequential conditioning regimen in patients with refractory or relapsed acute myeloid leukemia: A study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.
Am J Hematol;
93(3): 416-423, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29226497
5.
Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study.
Haematologica;
107(7): 1681-1686, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34965701
6.
Hematopoietic Stem Cell Transplantation in Multiple Myeloma: A Retrospective Study of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Biol Blood Marrow Transplant;
21(8): 1452-9, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25911579
7.
Comparison of umbilical cord blood allogeneic stem cell transplantation vs. auto-SCT for adult acute myeloid leukemia patients in second complete remission at transplant: a retrospective study on behalf of the SFGM-TC.
Eur J Haematol;
94(5): 449-55, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25238651
8.
Transplantation for myelofibrosis patients in the ruxolitinib era: a registry study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.
Bone Marrow Transplant;
2024 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38514813
9.
HLA haplotype frequencies and diversity in patients with hemoglobinopathies.
EJHaem;
4(4): 963-969, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38024588
10.
Improved outcome in children compared to adolescents and young adults after allogeneic hematopoietic stem cell transplant for acute myeloid leukemia: a retrospective study from the Francophone Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC).
J Cancer Res Clin Oncol;
148(8): 2083-2097, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34480598
11.
Impact of genetic abnormalities after allogeneic stem cell transplantation in multiple myeloma: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Haematologica;
96(10): 1504-11, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21685472
12.
[A standardized medical report template for CAR T-Cell therapy patients: Guidelines of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. / Lettre type pour les comptes rendus « CAR-T Cells ¼ : recommandations de la Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Bull Cancer;
108(12S): S82-S86, 2021 Dec.
Artículo
en Francés
| MEDLINE | ID: mdl-33933288
13.
Ruxolitinib before allogeneic hematopoietic transplantation in patients with myelofibrosis on behalf SFGM-TC and FIM groups.
Bone Marrow Transplant;
56(8): 1888-1899, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33767402
14.
Persistence of lymphocyte function perturbations after granulocyte-colony-stimulating factor mobilization and cytapheresis in normal peripheral blood stem cell donors.
Transfusion;
50(12): 2676-85, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20663114
15.
[How to capture cytogenetic and molecular abnormalities into ProMISe database for hematological malignancies: Guidelines from the francophone society of bone marrow transplantation and cellular therapy (SFGM-TC)]. / Modalités de capture des anomalies cytogénétiques et moléculaires pour la leucémie aiguë, le myélome multiple, le syndrome myélodysplasique, le syndrome myéloprolifératif et le syndrome myélodysplasique/myéloprolifératif : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC).
Bull Cancer;
107(1S): S52-S61, 2020 Jan.
Artículo
en Francés
| MEDLINE | ID: mdl-31615645
16.
[Reporting data of patients receiving CAR T cell therapy into the EBMT registry: Guidelines of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. / Saisie des données des patients faisant l'objet d'un traitement par cellules CAR-T : recommandations de la Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Bull Cancer;
107(12S): S178-S184, 2020 Dec.
Artículo
en Francés
| MEDLINE | ID: mdl-31831153
17.
Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE).
Bone Marrow Transplant;
55(4): 681-694, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31636397
18.
Correction: Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE).
Bone Marrow Transplant;
55(4): 838-839, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31754251
19.
[Harmonization of data coding in post-transplant follow-up - "GVHD, complications and additional treatments": Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. / Harmonisation du codage des données difficiles du post-greffe « GVHD, complications et traitements additionnels ¼ : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC).
Bull Cancer;
106(1S): S71-S82, 2019 Jan.
Artículo
en Francés
| MEDLINE | ID: mdl-30448095
20.
Use of letermovir in umbilical cord blood transplantation based on risk scores.
Blood Adv;
7(16): 4315-4318, 2023 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37276384